irievibes
irievibes
Sex: F
Data Quality: 1 star
MS: 14 yrs
Type: Relapsing-Remitting
Sensation: None
Overall: Mild
Cognition: moderate
Vision: mild
Speech: mild
Swallowing: none
Upper limb: moderate
Walking: moderate
irievibes
Female, 34 years
Portland, OR
Primary Condition
MS
Type
Relapsing-Remitting
First symptom
May 1998
Diagnosis
May 1998
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

irievibes's Interferon beta-1a SubQ injection is for:

  • MS

irievibes's side effects of Interferon beta-1a SubQ injection:

irievibes's Interferon beta-1a SubQ injection History (Ongoing)
30 mg Weekly May 15, 1998 - Sep 15, 2005
60 mg Weekly Sep 15, 2005 - Last Update
Evaluations
Date Dosage MS (Multiple Sclerosis) Efficacy Side Effects Adherence Burden
Nov 02, 2009 60 mg Weekly Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 MildMildMildMild AlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhat
Sep 23, 2008 60 mg Weekly Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 MildMildMildMild AlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhat
Date
Nov 02, 2009
Advice & Tips
Aleeve!
Cost
$200+ monthly
Date
Sep 23, 2008
Advice & Tips
they don't have to do it themselves
Cost
$200+ monthly

About Interferon beta-1a SubQ injection (Prescription Drug)

Interferon beta-1a is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It comes as a solution to inject subcutaneously (under the skin) three times a week, ideally the same 3 days each week.

Learn more about Interferon beta-1a SubQ injection in our Interferon beta-1a SubQ injection Community Report.